Monday, November 6, 2017
- 4:30PM-6:00PM
-
Abstract Number: 1871
Identifying Pain Sites Highly Associated with the Fibromyalgia (FM) Phenotype
Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes- 4:30PM-6:00PM
-
Abstract Number: 1857
If Mobile Advertising Is the Future, the Future Is Now: Productivity of Digital Ads By Terminology and Delivery Device.
ARHP Education/Community Programs- 4:30PM-6:00PM
-
Abstract Number: 1896
IL-18 As a Diagnostic Biomarker, Differentiating Systemic JIA from Acute Leukaemia, Severe Bacterial Infections and Other Auto-Immune Disorders
Pediatric Rheumatology – Clinical and Therapeutic Aspects I: Autoinflammatory Diseases- 4:30PM-6:00PM
-
Abstract Number: 1911
Impaired Control of Autoreactive T Cell Expansion Is Coupled with Type-1 Regulatory T Cell Deficiency in BALB/c ZAP70W163C Mutant Mice
Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology- 4:30PM-6:00PM
-
Abstract Number: 1863
Inflammatory Dietary Pattern and Risk of Developing Rheumatoid Arthritis in Women
ACR/ARHP Combined: Epidemiology and Public Health: Prevention, Recognition, and Treatment- 4:30PM-6:00PM
-
Abstract Number: 1913
Inter-Omic Analysis Reveals Functional Relationship between Diverse Gut Microbiota and Dysregulated Host Immune Response in HLA-B27-Mediated Experimental Spondyloarthritis
Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology- 4:30PM-6:00PM
-
Abstract Number: 1909
Long Term Safety of Filgotinib in the Treatment of Rheumatoid Arthritis: Week 84 Data from a Phase 2b Open-Label Extension Study
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy II: Trials Therapy- 4:30PM-6:00PM
-
Abstract Number: 1908
Long-Term Efficacy and Safety Results of a Global Phase 3 Trial of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumatic Drug Treatment
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy II: Trials Therapy- 4:30PM-6:00PM
-
Abstract Number: 1864
Longitudinal Changes in Serum Uric Acid Levels and Associated Risk of Cardiometabolic Events and Renal Insufficiency in Gout Patients
ACR/ARHP Combined: Epidemiology and Public Health: Prevention, Recognition, and Treatment- 4:30PM-6:00PM
-
Abstract Number: 1891
Low Alkaline Phosphatase Levels: Could It be Hypophosphatasia?
Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis- 4:30PM-6:00PM
-
Abstract Number: 1879
Majority of Rheumatoid Arthritis Patients in Clinical Remission As Defined By DAS-28, CDAI, SDAI and RAPID-3 Have No Signal on Ultrasound Power Doppler
Imaging of Rheumatic Diseases I: Novel Imaging and Scoring Systems- 4:30PM-6:00PM
-
Abstract Number: 1859
Meeting the Needs of Rheumatology Health Professional Learners: the Success of the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP) Online Educational Products
ARHP Education/Community Programs- 4:30PM-6:00PM
-
Abstract Number: 1884
Mepolizumab for the Treatment of Patients with Eosinophilic Granulomatosis with Polyangiitis: Post-Hoc Results of a Phase III Randomized, Placebo-Controlled Trial
Miscellaneous Rheumatic and Inflammatory Diseases I- 4:30PM-6:00PM
-
Abstract Number: 1865
Novel Approach to Arthritis Surveillance Suggests a Much Higher Prevalence of Arthritis Among US Adults Than Previous Estimate